Letter: Using a Placebo as a Comparator to Rifaximin for the Primary Prophylaxis of Spontaneous Bacterial Peritonitis-Is There Really an Ethical Concern?
Alimentary Pharmacology and Therapeutics- United Kingdom
doi 10.1111/apt.14544
doi 10.1111/apt.14544